Pfizer Inc.

NYSE:PFE   3:59:57 PM EDT
+0.25 (+0.49%)
5:28:07 PM EDT: $51.70 -0.03 (-0.06%)
Products, Regulatory

Pfizer To Provide U.S. Government With 10 Million Treatment Courses Of experimental COVID-19 antiviral drug

Published: 11/18/2021 11:57 GMT
Pfizer Inc. (PFE) - Pfizer to Provide U.S. Government With 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat Covid-19.
Pfizer Inc - Seeking Emergency Use Authorization of Paxlovid With U.S. FDA and is Working to Submit Applications to Regulatory Agencies Around World.
Pfizer Inc - Agreement With U.S. Government to Supply 10 Million Treatment Courses of Its Investigational Covid-19 Oral Antiviral Candidate, Paxlovid.
Pfizer Inc - Will Receive $5.29 Billion From U.S. Government, Pending and Contingent Upon Regulatory Authorization.
Pfizer Inc - Will Continue to Invest Up to About $1 Billion of Its Own Funds to Manufacturing and Distribution of Investigational Treatment Candidate.
Pfizer Inc - Price Being Paid by U.S. Government is Reflective of High Committed Volume of Treatment Courses Being Purchased Through 2022.